Requirement of STAT3 Activation for Differentiation of Mucosal Stratified Squamous Epithelium
- 46 Downloads
STAT3, a member of the signal transducers and activators of transcription (STAT) family, has been shown to play a key role in promoting proliferation, differentiation, or cell cycle progression, depending on cell type. A number of signaling pathways are altered in laryngeal papillomas, benign tumors induced by human papillomavirus 6/11. Papillomas overexpress the epidermal growth factor receptor and display enhanced MAP kinase and PI-3-kinase activity. They also show reduced activation of Akt and reduced levels of tyrosine-phosphorylated STAT3, due to overexpression of the tumor suppressor, PTEN. As papillomas show abnormalities in terminal differentiation, we examined the potential role of STAT3 in regulating epithelial differentiation. Laryngeal epithelial cells were suspended in supplemented serum-free medium. Differentiation was measured by Western blot analysis of keratin 13. Normal laryngeal epithelial cells were transfected with a constitutively active STAT3 or a dominant negative STAT3. Cells were transferred to suspension culture 24 h after transfection. Increased expression of keratin 13 was accompanied by the activation of STAT3 when differentiation was induced, and expression of a constitutively active STAT3 (STAT3C) enhanced the expression of keratin 13. In contrast, expression of a dominant negative STAT3 (Y705F) inhibited the expression of keratin 13. We conclude that activation of STAT3 is required for the differentiation of normal human stratified squamous epithelium.
Laryngeal papillomas are benign squamous epithelial tumors caused by infection of the low-risk Human Papillomavirus (HPV) type 6 or 11 (1). They are characterized by a hyperplastic supra-basal epithelium surrounding cords of connective tissues (2). The process of epithelial differentiation is complex, involving the coordinated step-wise change in expression of multiple genes. Papillomas display abnormal differentiation, as indicated by a drastic reduction of keratin 13, a mucosal epithelial differentiation marker (3). Basal cells of all stratified squamous epithelia display a keratin network composed of the type II keratin, K5, and the type I keratin, K14 (4,5). Other keratin pairs, such as K4 and K13, are expressed in suprabasal-stratified squamous epithelia (6). These are markers of early differentiation. In both skin and mucosa, the outer layers of terminally differentiated cells are replenished by the basal proliferating keratinocytes. Basal cells proliferate and either retain the stem cell characteristics or migrate outwards and differentiate. This dynamic transition is accompanied by drastic alterations in gene expression programming (7). Signal transduction in HPV-infected papilloma cells is altered. They express elevated levels of the epidermal growth factor receptor (EGFR) (8,9), which lead to constitutively activated MAP kinase and enhanced PI3 kinase activity. Papillomas show reduced activation of protein kinase B (PKB or Akt) (10) and reduced levels of phosphorylated STAT3 due to overexpression of the tumor suppressor, PTEN (11). Negative regulation of STAT3 by PTEN immediately implies a role of STAT3, a transcription factor implicated in the differentiation of a variety of hematopoietic cells (12, 13, 14), in mediating the abnormal differentiation of HPV-infected papilloma tissues.
STAT3 is a member of the signal transducer and activator of transcription (STAT) family (STAT1, STAT2, STAT3, STAT4, STAT5a, STAT5b, and STAT6). The activation of STAT has been linked with both the receptor-associated tyrosine kinases, including Janus-activated kinases Src and Abl, as well as the receptor tyrosine kinases, such as EGFR and platelet-derived growth factor receptor (15, 16, 17, 18). Upon tyrosine phosphorylation, STATs form hetero- or homodimers and translocate to the nucleus. Dimerized STAT then binds to a specific promoter-proximal element, thereby activating transcription of target genes (19). STAT3, in particular, has been reported as a proto-oncogene (20) and has been shown to play a role in EGF-induced proliferation in head and neck squamous carcinoma cells (21). STAT3 is activated by EGFR activation (22). However, STAT3 has been shown to play important roles in the differentiation of myeloid leukemia cells (12,23, 24, 25), murine hematopoietic cells (14,26), and rat hepatocytes (27, 28, 29). Its role in epithelial differentiation is unclear. Because reduced expression of K13 (3) is accompanied by reduced activation of STAT3 (11) in HPV-infected papilloma tissue, we have asked whether STAT3 plays a role in the differentiation of human mucosal epithelium. This report provides evidence indicating that activation of STAT3 is required for the induction of K13 during keratinocyte differentiation.
Materials and Methods
Tissue Handling and Cell Culture
Surgical discards of normal laryngeal tissues and HPV-infected laryngeal papillomas were derived from patients. Epithelial explant cultures of normal human laryngeal cells or papilloma cells were established from biopsies in Ham’s F12 with 10 µg/mL hydrocortisone and 10 mL/100 mL Fetal Clone II (Hyclone, Logan, UT, USA), as described previously (30). Normal laryngeal cells were subcultured on mitomycin C-treated J23T3 feeder cells, as described (31). Multiple early passage cultures were used. The use of human tissues and cultured cells was approved by the Institutional Review Board at Long Island Jewish Medical Center.
This system mimics the in vivo environment for mucosal epithelium differentiation. The culture system used is a modification of Wakita and Takigawa (32) to induce differentiation of cultured human epidermal cells. Cultured normal epithelium cells were treated with 0.02% EDTA in phosphate-buffered saline to selectively remove J23T3 feeder cells. Normal laryngeal cells were trypsinized and replated in serum-free keratinocyte basal medium (KBM) (Clonetics, San Diego, CA, USA) supplemented with 0.15 mM calcium, 0.5 µg/mL hydrocortisone, 2 µg/mL transferrin, 1 ng/mL EGF, and 5 µg/mL insulin (KGM). After 24 h, cells were trypsinized and suspended in KGM supplemented with 1.4 mM calcium. Cells were cultured at a density of 1 × 105 cells/cm2 on 1% agarose-coated dishes (Nunc) to allow cell-cell contact, with cell-extracellular matrix contact blocked in order to promote differentiation. For control, monolayers of cells were cultured in 0.15 mM calcium KGM on tissue culture plastic at the same density. At indicated times, cells were washed with phosphate-buffer saline and lysates were prepared from harvested cells as described next.
Preparation of Extracts and Western Blot Analysis
Keratins were extracted using the method of Stasiak and others (33), which sequentially extracts the soluble cytoplasmic proteins, the nuclear proteins, and finally the detergent-insoluble keratins. Briefly, cells were lysed on ice with 50 of low salt extract buffer in the presence of complete protease inhibitor cocktail (Roche Molecular Biochemicals, Mannheim, Germany) and phosphatase inhibitors (20 mM α-glycerophosphate, 1 mM sodium orthovanadate, 30 mM sodium fluoride). Lysates were centrifuged at 2000 rpm for 10 min, and the pellets were extracted with 50 µL of high salt extract buffer in the presence of protease and phosphatase inhibitors. The extract was centrifuged at 14000 rpm for 10 min, the pellet was washed twice, and keratin was extracted by boiling for 5 min in 100μL electrophoresis sample buffer. For the determination of STAT3 activation, whole cell extracts were prepared by lysing cells with 1% NP-40, 0.4 M NaCl, 1% glycerol, 1 µM dithiothreitol, and the protease/phosphatase inhibitor as described above. Protein concentrations of the lysates were determined by Micro BCA reagents (Pierce, Rockford, IL, USA). Western blot was performed as previously described (34). Protein (40 µg) was loaded per lane on a 7.5% SDS-PAGE acrylamide gel, and electroblotted onto a nitrocellulose membrane (Shleicher & Shull, Keene, NH, USA). Standard molecular weight marker (Bio-Rad, broad range, Hercules, CA, USA) was used for molecular weight estimation. Blots were stained with Fast green (35) to confirm equivalence in loading and transfer. The immunoreactive species were detected by using Super Signal West Pico chemiluminescent substrates (Pierce, Rockford, IL, USA). After probing with anti-phospho STAT3 or anti-keratin 13, the membrane was stripped, and reprobed with anti-STAT3 or anti-keratin 14, respectively. Signal intensity was quantified by UN-SCAN-IT Program (Silk Scientific Inc, Orem, Utah, USA).
Plasmids and Antibodies
pSTAT3C (a gift from Dr James E Darnell, Jr), an expression plasmid that generates constitutively activated STAT3, has been described (22). A hemagglutinin peptide (HA)-tagged dominant negative STAT3 (Y705F) (gift of Dr Jennifer Rubin Grandis) has been previously described (36). Dr Danile Besser donated pTATA-4XM67-Luc and control plasmid pTATA-Luc (37). pHygEGFP was from Clontech (Palo Alto, CA, USA). Anti-PTyr (705) STAT3 and Anti-STAT3 (pan) polyclonal rabbit antibodies were purchased from Cell Signaling Technology (Beverly, MA, USA). Anti-keratin 13 and anti-keratin 14 monoclonal antibodies were from Novocastra Laboratories (Newcastle upon Tyne, UK). Polyclonal rabbit anti-STAT3 and anti-phospho (Tyr-705)-STAT3 were used at 1:500 dilution. Anti-keratin 13 was used at 1:2500 dilution, anti-keratin 14 was used at 1:12500 dilution. Horseradish peroxidase-conjugated secondary antibodies were purchased from Pierce (Rockford, IL, USA). For immunohistochemistry staining, Vectastain Elite ABC Kit (Vector Laboratories, Burlingame, CA, USA) was used.
Morphological Analyses and Immunohistochemistry Staining
Normal laryngeal and papilloma specimens were fixed in 10% buffered formalin, paraffin-embedded, and processed for histological study by conventional methods. Cultured normal cells were cytospun onto glass slides, followed by immunohistochemistry staining. Five fields were counted per slide with approximately 150 cells/field. The percentage of cells that stained positive for K13 staining in the cytoplasm was determined by microscopic examination. Immunostaining was performed based on previously reported procedure (38). Sections were deparaffinized, submerged in methanol containing 0.3% hydrogen peroxide for 30 min at room temperature to inhibit endogenous peroxidase activity, blocked with 1.5% normal horse serum, and immunostained using the avidin-biotin-complex (ABC) method with diaminobenzidine as label (Vectastain ABC Elite Kit) according to the supplier’s instructions. Antigen retrieval procedure (10 mmol/L heated citrate buffer [pH 6.0] in a microwave oven for 10 min) was performed only for phosphorylated STAT3. The slides were then incubated with the primary antibodies at 1:50 dilution. Sections without the addition of the primary antibodies served as controls. Counterstaining was performed for 30 s with hematoxylin.
Normal laryngeal epithelial cells were transfected with various amounts of plasmid cDNA using Lipofectamine Plus reagents (Life Technologies, Rockville, MD, USA) according to manufacturer’s instructions. Twenty-four hours after transfection, cells were transferred to suspension culture, as described above. Using this procedure, approximately 50% of cells are transfected (data not shown).
Typically, transfections contained a total of 3 µg of DNA. This included 1 μg of either the STAT3 responsive pTATA-4XM67-Luc or control pTATA-Luc luciferase reporter construct, 0.5 of pHygEGFP expression construct, and 1.5 µg of STAT3C or STAT (Y705F), control empty vectors pcDNA3 (Invitrogen, Carlsbad, CA, USA), or pCAGGS-Neo. Cytosolic lysates were prepared at 0, 24, and 48 h post-suspension, and luciferase assays were performed using a commercial luciferase assay kit (Promega, Madison, WI, USA). Luciferase activity of the lysates was measured using a TD-20/20 luminometer (Turner Designs, Sunnyvale, CA, USA). STAT3-driven luciferase expression was determined by subtracting the background activity obtained with pTATA-Luc transfection after normalizing to green fluorescent protein for transfection efficiency. The final luciferase activity was expressed as a percentage relative to that of the control transfection with pcDNA3 or pCAGGS-Neo at 0 time.
The XTT Assay
The XTT (TOX-2) system (Sigma, St. Louis, MO, USA) is a measurement of metabolic viability. XTT was used to assess cell death resulting from transfecting STAT3 mutant (STAT3C and Y705F) constructs in suspension culture. Cells (2 × 105) from suspension culture were plated in 96-well tissue culture plates at the indicated times. Triplicate experiments were performed. Cells were incubated with XTT and absorbance at 450 nm was measured using a Microplate Reader (Bio Whittaker, Rockland, ME, USA).
Phospho-STAT3 and Keratin 13 Are Reduced in Papilloma Tissue
Suspension Culture Induces Differentiation of Normal Human Stratified Squamous Epithelium, but Not HPV-infected Papilloma Cells
STAT3 Activation Is Enhanced in Suspension Culture
Constitutively Active STAT3 (STAT3C) Enhances Differentiation and Dominant-Negative STAT3 Blocks Keratinocyte Differentiation
The extrinsic cues that determine cell proliferation compared with cell death compared with cell differentiation depend on ligand-induced, receptor-mediated signals, including cell-cell and cellmatrix interactions. The biologic effects of receptor-mediated, growth factor-induced signaling may differ between suprabasal and basal keratinocyte cell layers, since proliferation of normal stratified squamous epithelium is stimulated only in the presence of cell-extracellular matrix interaction (40). In this report, we have shown that normal laryngeal cell differentiation was induced by suspension culture, by which cell-extracellular matrix interaction was blocked while cell-cell interaction was maintained. In contrast, laryngeal papilloma cells failed to differentiate in suspension culture. Thus, this culture condition reproduced the in vivo differentiation phenotype of normal cells and papillomas, at least in part. STAT3 activation has been shown to correlate with differentiation of primary mouse skin keratinocytes (41). According to that report, STAT3 is activated in keratinocytes, which are in a stage of growth arrest and differentiation. Consistent with this, our investigation showed that STAT3 becomes activated during human keratinocyte differentiation. Dominant-negative STAT mutants have been used to test whether STAT activation is required for survival of squamous cell carcinoma of head and neck (21) and cytokine-induced differentiation of myeloid leukemia M1 cells (12) and bone marrow cells (13). In our studies, transfection of a dominant negative STAT3 (Y705F) into the normal laryngeal cells inhibited the expression of differentiation-specific K13. Additionally, transfection of a constitutively active STAT3 into normal laryngeal cells increased the expression of K13. To our knowledge, this is the 1st report demonstrating that activation of STAT3 regulates differentiation of normal human stratified squamous epithelium.
The effect of STAT3-mediated promotion of differentiation could be direct or indirect, or both. Several transcription factors are known to regulate transcription of differentiation-specific genes. For example, Skn-1a and Skn-1i activate transcription of the keratin 10 promoter, whereas Tst-1/Oct-6 transcription represses keratins 5 and 14 (42,43). Sp1 and AP2 transcription factors also were shown to be important for the up-regulation of keratin genes during differentiation (44,45). Potential STAT3 binding sites (18) at −123 to −113 and at −51 to −340 are located in the K13 promoter region (46). Moreover, a reverse complementary site is found at −271 to −260. We believe that these sequences may confer STAT3 binding and subsequent transactivation of the K13 promoter. C-Myc and transforming growth factor β-induced transcription factors are well documented to function as molecular switches that convert the cellular program from proliferation to differentiation in other cell types (47,48). In this regard, it is conceivable that STAT3 may act as a program converter during laryngeal epithelial cell differentiation.
Human papillomavirus (HPV) types 6 or 11 causes benign tumors of mucosal epithelium. These tumors are characterized by slow proliferative rates, abnormal terminal differentiation (3), and a low probability of malignant conversion. We previously reported that HPV 6/11-infected tissues show increased expression of the EGFR in both basal and suprabasal cells (9). We also documented reduction in the activation of both Akt and STAT3, due to increased expression of PTEN, a dual specificity phosphatase, in HPV-infected papillomas (10,11). Judging from our immunohistochemical findings (Figure 1), nuclear phospho-STAT3 was abundant in the upper layer of normal laryngeal epithelium where keratinocytes had differentiated. In contrast, there was little phospho-STAT3 in HPV-infected laryngeal papillomas where abnormal differentiation was observed, consistent with the notion that STAT3 regulates keratinocyte differentiation. Data obtained by expressing mutant STAT3 imply that reduced STAT3 activation, due to overexpression of PTEN, may contribute to the differentiation defect in HPV-infected papillomas. Apart from the STAT3 pathway, we are currently investigating potential roles of the MAP kinase and PI-3-kinase/Akt pathways in the regulation of differentiation of normal mucosal epithelial cells, since both are altered in papillomas. Interestingly, our preliminary data indicate that both these 2 signaling pathways also appear to contribute to normal laryngeal cell differentiation (Dackour and others, personal communication). A model of this interaction is shown in Figure 7. If this model is correct, it may prove necessary to restore both AKT and STAT3 to induce papilloma cell differentiation. These studies are continuing.
In summary, the studies reported here have demonstrated that STAT3 activation is required for keratinocyte differentiation in normal human stratified squamous epithelium. The suspension culture mimics the in vivo differentiation of normal laryngeal cells and HPV-infected papilloma cells and can be used as a model system for studying regulatory mechanisms of differentiation in human stratified squamous epithelium. Furthermore, our findings may prove useful in developing a STAT3-targeting strategy to enhance differentiation in HPV-infected laryngeal epithelial cells, thereby providing a potential alternative treatment for this disease.
This work was supported by grant P50DC00203 from the National Institute on Deafness and Other Communication Disorders and a Faculty Research Award from the North Shore-Long Island Jewish Research Institute.
We thank Dr Jennifer Grandis and Dr James Darnell who provided the dominant-negative STAT3 and the constitutively active STAT3. We express our gratitude to Dr Danile Besser who provided the STAT3 luciferase reporter and control constructs. Also, we thank Dr Allan Abramson and Dr Mark Shikowitz who provided normal and papilloma tissues, and May Nouri who provided normal laryngeal cell cultures.
- 1.Gissman L, Diehl B, Schults-Coulon J, zur Hausen H. (1982) Molecular cloning and characterization of human papillomavirus DNA derived from a laryngeal papilloma. J. Virol. 44:393–9.Google Scholar
- 6.Sun TT, Eichner R, Schermer A, Cooper D, Nelson WG, Weiss R.A. (1984) Classification, expression, and possible mechanisms of evolution of mammalian epithelial keratins: a unifying model. In: Cancer cells/1. The transformed phenotype. Levine AJ et al (ed.). N.Y.: Cold Spring Harbor Laboratory Press. p 169–76.Google Scholar